DRKS00005719招募中不适用
Thiotepa in autologous stem cell transplantation (ASCT):A non-interventional, prospective study to assess safety and efficacy of Thiotepa-based high dose chemotherapy (HDCT) prior to autologous stem cell transplantation in adults with B- or T-cell lymphoma (non-Hodgkin lymphoma or Hodgkin lymphoma) with or without CNS involvement or with primary CNS lymphoma.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •signed informed consent form
- •- age = 18 years
- •- patients with a documented B- or T-cell lymphoma (non-Hodgkin lymphoma or Hodgkin lymphoma) with or without CNS involvement or with primary CNS lymphoma
- •- first autologous stem cell transplantation (ASCT)
- •- Thiotepa-based high dose chemotherapy prior to ASCT
排除标准
- •Contraindications:
- •Hypersensitivity to the active substance.
- •Pregnancy and lactation
- •Concomitant use with yellow fever vaccine and with live virus and bacterial vaccines
研究者
相似试验
已完成
2 期
TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in LymphomaMalignant LymphomaNCT03346096Sheba Medical Center50
招募中
3 期
Allogeneic Stem Cell Transplantation (SCT) for children and adolescents with acute lymphoblastic Leukaemia (ALL)cancer of the blood10024324leukaemiaNL-OMON54836St, Anna Kinderkrebsforschung35
已完成
不适用
autologous hematopoietic stem cell transplantation followed by reduced intensity allogeneic stem cell transplantation for relatively young patients with multiple myelomamultiple myelomaJPRN-UMIN000002533The university of Tokyo Hospital,department of hematology and oncology20
招募中
不适用
Autologous stem cell transplantation for the treatment of refractory Crohn*s disease: mechanisms of succesNL-OMON39547Sint Antonius Ziekenhuis15
进行中（未招募）
1 期
Stem Cell Transplantation and Maintenance Therapy with Thalidomide / DLI for patients with Multiple MyelomaEUCTR2007-004928-21-DEniversity Medical Center Hamburg-Eppendorf220